IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA

  • Test Usage:
    Imatinib is a Tyrosine kinase inhibitor (TKI) capable of inducing durable hematologic and cytologic remissions in patients with Chronic Myeloid Leukemia (CML). Unfortunately a significant subset of patients develop functional resistance to TKI. Recognition of this resistance is important in CML as the effect of some mutations can be overcome by Imatinib dosage.
  • Report Availability:
    Sample by Mon 11 am; Report Sat
  • Sample Report:
10 Diagnostic Centers found for IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA in Amritsar